GLP-1s & medical weight loss
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed obesity and metabolic disease treatment. We cover how they work, who they're for, how to evaluate providers, and what the emerging research says about long-term use.
Read our GLP-1 guide →Peptide therapy
BPC-157, CJC-1295/Ipamorelin, thymosin variants, and the broader landscape of therapeutic peptides. What the research actually supports, what it doesn't, and how to separate hype from legitimate clinical use.
Coming soonHormone health & BHRT
Bioidentical hormone replacement, perimenopause, andropause, thyroid, and the diagnostic testing behind good hormone medicine. The science and the practical reality.
Coming soonLongevity & healthspan
Sifting through longevity research to find what's actually supported by evidence: rapamycin, metformin, NAD+ precursors, exercise protocols, and the biomarkers worth tracking.
Read our longevity guide →Metabolic health
Insulin resistance, continuous glucose monitoring, fasting, and the metabolic foundations underlying most chronic disease. Tools and frameworks for understanding your own metabolic state.
Coming soonNutrition & gut health
Food sensitivities, the microbiome, leaky gut, SIBO, and how digestive health influences hormones, inflammation, and overall wellbeing.
Coming soon